Found 21 matching trials
Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome N/A This is a standard of care treatment guideline for patients with the diagno...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Intrathecal Enzyme Replacement for Hurler Syndrome PHASE1 This protocol will examine whether the enzyme alpha-L-iduronidase (Laronida...
Show More Location
University of Minnesota, Fairview
Learn More & Join Trial
A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants PHASE4 The purpose of this study is to determine if laronidase is present in the b...
Show More Location
Dipartimento di Scienze Pediatriche Medico - Chirurgiche e Neuro Scienze dello Suiluppo
Learn More & Join Trial
Immune Tolerance Study With Aldurazyme® (Laronidase) PHASE1 The purpose of this study is to see if treatment with an antigen-specific i...
Show More Learn More & Join Trial
Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I PHASE1 This is a one-year extension study of the use of laronidase into the spinal...
Show More Location
Los Angeles Biomedical Research Institute at Harbor-UCLA
Learn More & Join Trial
China Post-marketing Surveillance (PMS) Study of Aldurazyme® PHASE4 This is a single treatment arm study that is open-label to be conducted in ...
Show More Location
Investigational Site Number :1560003
Learn More & Join Trial
Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients PHASE3 This study is being conducted to collect additional long-term efficacy and ...
Show More Location
University of South Alabama
Learn More & Join Trial
Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I PHASE1 The investigators are studying the use of enzyme replacement therapy into t...
Show More Location
Los Angeles Biomedical Research Institute at Harbor-UCLA ( LA BioMed )
Learn More & Join Trial
Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in MPS I NA This is a five-year extension study of the pilot study, "Intrathecal Enzyme...
Show More Location
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Learn More & Join Trial
Efficacy and Safety of YW17 (Laronidase-CinnaGen) Compared to Aldurazyme® in MPS I Patients PHASE3 The purpose of this phase III study is to assess the efficacy and safety of...
Show More Location
Clinical Research Development Unit of Akbar Hospital, Faculty of Medicine
Learn More & Join Trial